The EU had previously approved two vaccines for protecting ... "This approval of the first mRNA vaccine against RSV clearly shows the importance of innovation when it comes to protecting the ...

GSK plc GSK has announced the approval of the European Commission (EC) for the expanded use of its respiratory syncytial ...

The company's vaccine consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein.

The EU follows the US in approving the use of the shot in the younger age range in people with conditions like chronic ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

The first real-world study highlights benefits for adults aged 60 years and older who receive the respiratory syncytial virus ...

In adults 60 and over, vaccine effectiveness from October 2023 to March 2024 against RSV-associated hospitalization reached ...

The updated COVID-19 vaccines are officially available at U.S. pharmacies across the country. Here are other vaccines recommended for adults.

The European Commission on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- the first ...